IART Integra LifeSciences Holdings Corporation

Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)

Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)

New global medical education platform offers digital tools to keep HCPs at the forefront of medical knowledge

PRINCETON, N.J., Jan. 14, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, today announced the launch of its global medical education platform . This new digital resource is designed to elevate Integra’s medical education offerings in surgical, neurologic, ENT and regenerative care​ by enhancing professional development through a wealth of on-demand learning resources.

The Integra Institute platform is designed for healthcare providers (HCPs) in the United States and EMEA across multiple medical specialties, tailored to a variety of experience levels. The curated hub includes on-demand webinars on complex medical scenarios​, surgical videos showcasing the latest techniques and best practices​ and an events calendar for continuous learning and networking.

“Integra is a longstanding partner to HCPs who work on complex procedures with a profound impact on patients’ lives. We are proud to build on our strong partnerships with this community by developing a premier, one-stop-shop in professional education,” said Kristen Hedstrom, Integra’s vice president of professional education and divisional market access.

“HCPs often look for efficient, digital tools to stay up to date with the latest guidance in our fields and advance patient outcomes. I am excited about the Integra Institute and its facilitation of convenient learning and collaboration across the industry,” said Dr. Said Azoury, plastic and reconstructive surgeon and assistant professor of surgery at the Hospital of the University of Pennsylvania.

Interested clinicians can explore the site by registering for an account at: .

About Integra LifeSciences

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit

Contacts:

Media

Laurene Isip



Investor Relations

Chris Ward





EN
14/01/2025

Underlying

Reports on Integra LifeSciences Holdings Corporation

 PRESS RELEASE

Integra LifeSciences to Host Second Quarter 2025 Financial Results Con...

Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025 PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release second quarter 2025 financial results on Thursday, July 31, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register  to receive dial-in...

 PRESS RELEASE

Integra LifeSciences Announces First Patient Enrolled in Acclarent AER...

Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first patient in the Acclarent AERA Pediatric Registry, a prospective, multi-center observational registry evaluating the real-world use of the in children. This inaugural enrollment marks the focused effort to measure the ongoing, real-world clinical performance of AERA in pediatric patients with obstructive Eustachian tube dysfunction (ETD). Dr....

 PRESS RELEASE

Integra LifeSciences Reports First Quarter 2025 Financial Results

Integra LifeSciences Reports First Quarter 2025 Financial Results PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2025. First Quarter 2025 Highlights First quarter revenues of $382.7 million increased 3.7% on a reported basis and decreased 3.5% on an organic basis compared to the prior year. First quarter GAAP earnings per diluted share of $(0.33), compared to $(0.04) in the prior year; adjusted earnings per diluted share of $0.41, compared to $0.55...

 PRESS RELEASE

Integra LifeSciences to Host First Quarter 2025 Financial Results Conf...

Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release first quarter 2025 financial results on Monday, May 5, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register  to receive dial-in detail...

 PRESS RELEASE

Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthc...

Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer will present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 17, 2025 at 10:00am ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at . About Integra LifeSciencesAt Integra LifeScien...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch